NorthWest Biotherapeutics Inc (NWBO)

[staccani]

DCVax Direct had a very remarkable effect (between 80%-100% cancer remission within a couple of months, plus immunization as well) in mice.
If it works also with humans, it will likely have the same quick effect, since it is directly injected into the tumor.
DCVax Direct Phase I/II trial is unblinded, so the company must have been receiving regular updates. Then they booked 5 booths at ASCO, submitted a paper, prepared for large scale manufacturing. Insiders are not selling and have large stakes, and in fact have recently increased their stakes through the Cognate mfg deal, and institutions are accumulating.
Small investors are unaware at the moment but insiders, and anyway people who have access to first hand information as investment funds (and the Street continous bashing is another good sign as it is just a way for HF's to accumate more shares) must know how things are going with the DCVax Direct trial. All signs are very bullish.
One question though. Considering that DcVax direct trial is unblinded, and considering the huge importance this has for the future of the company and its shareholders, isn't the company OBLIGED to update investors on how things are progressing on a timely basis?